Selected Reads

Smartkarma

Equity Bottom-Up

Situation Overview: Select merger arbitrage spreads are currently dislocated due to a few factors including Elizabeth Warren’s recent letter writing campaign against various transactions including Microsoft’s acquisition of Activision Blizzard...<a target="_blank" href="https://www.valueinvestorsclub.com/idea/HORIZON_THERAPEUTICS_PUB_LTD/0533718787">Read the article on Value Investor Club »</a>

United States

Horizon Pharma plc operates as a biopharmaceutical company. Horizon Pharma develops, acquires, and commercializes late-stage biopharmaceutical therapies for the treatment of pain and inflammation as well as specialty and orphan diseases.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00